Fagron ARSUF Stock
Fagron Price Chart
Fagron ARSUF Financial and Trading Overview
| Fagron stock price | 27.5 USD |
| Previous Close | 27.5 USD |
| Open | 27 USD |
| Bid | 24.7 USD x 10000 |
| Ask | 27.8 USD x 10000 |
| Day's Range | 27 - 27 USD |
| 52 Week Range | 23.5 - 27.9 USD |
| Volume | 2.5K USD |
| Avg. Volume | 6 USD |
| Market Cap | 2.02B USD |
| Beta (5Y Monthly) | 0.381 |
| PE Ratio (TTM) | 19.097221 |
| EPS (TTM) | 1.44 USD |
| Forward Dividend & Yield | 0.4 (1.48%) |
| Ex-Dividend Date | May 19, 2025 |
| 1y Target Est | N/A |
ARSUF Valuation Measures
| Enterprise Value | 2.53B USD |
| Trailing P/E | 19.097221 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.9611081 |
| Price/Book (mrq) | 2.9415445 |
| Enterprise Value/Revenue | 2.458 |
| Enterprise Value/EBITDA | 14.482 |
Trading Information
Fagron Stock Price History
| Beta (5Y Monthly) | 0.381 |
| 52-Week Change | 9.12% |
| S&P500 52-Week Change | 21.71% |
| 52 Week High | 27.9 USD |
| 52 Week Low | 23.5 USD |
| 50-Day Moving Average | 26.76 USD |
| 200-Day Moving Average | 25.77 USD |
ARSUF Share Statistics
| Avg. Volume (3 month) | 6 USD |
| Avg. Daily Volume (10-Days) | 10 USD |
| Shares Outstanding | 73.35M |
| Float | 65.85M |
| Short Ratio | N/A |
| % Held by Insiders | 0.29% |
| % Held by Institutions | 71.51% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.4 |
| Trailing Annual Dividend Yield | 1.45% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 8.91% |
| Operating Margin (ttm) | 13.72% |
| Gross Margin | 44.39% |
| EBITDA Margin | 16.97% |
Management Effectiveness
| Return on Assets (ttm) | 6.97% |
| Return on Equity (ttm) | 16.70% |
Income Statement
| Revenue (ttm) | 1.03B USD |
| Revenue Per Share (ttm) | 14.04 USD |
| Quarterly Revenue Growth (yoy) | 16.00% |
| Gross Profit (ttm) | 456.62M USD |
| EBITDA | 174.59M USD |
| Net Income Avi to Common (ttm) | 91.74M USD |
| Diluted EPS (ttm) | 1.44 |
| Quarterly Earnings Growth (yoy) | 1.60% |
Balance Sheet
| Total Cash (mrq) | 131.19M USD |
| Total Cash Per Share (mrq) | 1.79 USD |
| Total Debt (mrq) | 637.63M USD |
| Total Debt/Equity (mrq) | 106.35 USD |
| Current Ratio (mrq) | 1.771 |
| Book Value Per Share (mrq) | 9.34883 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 160.91M USD |
| Levered Free Cash Flow (ttm) | 67.27M USD |
Profile of Fagron
| Country | United States |
| State | N/A |
| City | Nazareth |
| Address | Venecoweg 20A |
| ZIP | 9810 |
| Phone | 32 800 128 80 |
| Website | https://www.fagron.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 4880 |
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company's products include DiluCap, a line of excipients to compound every capsule formulation; DiluTab, for Cardiology and Primary care application; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort; and Cleoderm, a topical cream used for the compounding of personalized dermatological treatments. It also offers education and professional development of prescribers, hospitals, and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Q&A For Fagron Stock
What is a current ARSUF stock price?
Fagron ARSUF stock price today per share is 27.5 USD.
How to purchase Fagron stock?
You can buy ARSUF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fagron?
The stock symbol or ticker of Fagron is ARSUF.
Which industry does the Fagron company belong to?
The Fagron industry is Drug Manufacturers - Specialty & Generic.
How many shares does Fagron have in circulation?
The max supply of Fagron shares is 73.35M.
What is Fagron Price to Earnings Ratio (PE Ratio)?
Fagron PE Ratio is 19.09722100 now.
What was Fagron earnings per share over the trailing 12 months (TTM)?
Fagron EPS is 1.44 USD over the trailing 12 months.
Which sector does the Fagron company belong to?
The Fagron sector is Healthcare.
